Theravance Biopharma Inc (TBPH)
8.96
-0.05
(-0.55%)
USD |
NASDAQ |
Mar 28, 16:00
8.97
+0.01
(+0.11%)
Pre-Market: 20:00
Theravance Biopharma Total Return Level: 8.96 for March 28, 2024
Total Return Level Chart
Historical Total Return Level Data
Date | Value |
---|---|
March 28, 2024 | 8.96 |
March 27, 2024 | 9.01 |
March 26, 2024 | 8.82 |
March 25, 2024 | 8.76 |
March 22, 2024 | 8.92 |
March 21, 2024 | 8.96 |
March 20, 2024 | 9.01 |
March 19, 2024 | 8.85 |
March 18, 2024 | 8.65 |
March 15, 2024 | 8.64 |
March 14, 2024 | 8.61 |
March 13, 2024 | 8.80 |
March 12, 2024 | 8.52 |
March 11, 2024 | 8.57 |
March 08, 2024 | 8.62 |
March 07, 2024 | 8.69 |
March 06, 2024 | 8.74 |
March 05, 2024 | 8.67 |
March 04, 2024 | 9.10 |
March 01, 2024 | 9.44 |
February 29, 2024 | 9.47 |
February 28, 2024 | 9.40 |
February 27, 2024 | 9.69 |
February 26, 2024 | 9.23 |
February 23, 2024 | 8.98 |
Date | Value |
---|---|
February 22, 2024 | 8.675 |
February 21, 2024 | 8.76 |
February 20, 2024 | 8.92 |
February 16, 2024 | 8.80 |
February 15, 2024 | 8.67 |
February 14, 2024 | 8.46 |
February 13, 2024 | 8.35 |
February 12, 2024 | 8.58 |
February 09, 2024 | 8.58 |
February 08, 2024 | 8.22 |
February 07, 2024 | 8.50 |
February 06, 2024 | 8.82 |
February 05, 2024 | 8.85 |
February 02, 2024 | 8.90 |
February 01, 2024 | 9.16 |
January 31, 2024 | 9.48 |
January 30, 2024 | 9.77 |
January 29, 2024 | 10.03 |
January 26, 2024 | 9.91 |
January 25, 2024 | 9.91 |
January 24, 2024 | 9.81 |
January 23, 2024 | 9.93 |
January 22, 2024 | 9.66 |
January 19, 2024 | 9.47 |
January 18, 2024 | 9.52 |
Total Return Level Definition
The total return level allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions. Total return level is seen as the most accurate calculation that produces returns consistent with most other sources.
Total Return Level Range, Past 5 Years
6.77
Minimum
Sep 15 2021
31.21
Maximum
Feb 05 2020
14.74
Average
11.34
Median
Nov 17 2022
Total Return Level Benchmarks
Vanda Pharmaceuticals Inc | 4.11 |
Omeros Corp | 3.44 |
Fate Therapeutics Inc | 7.34 |
FibroGen Inc | 2.35 |
Voyager Therapeutics Inc | 9.29 |